Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Ironwood Pharma (IRWD) Reports Q2 Loss Per Share of 34c, Offers Guidance
August 5, 2015 4:23 PM EDTIronwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.34), may not compare to the analyst estimate of ($0.22). Revenue for the quarter came in at $27.7 million versus the consensus estimate of $36.53 million.
2015 Financial Guidance.
Ironwood continues to expect its 2015 total operating expenses to... More



